Is QC10 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of QC10 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate QC10's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate QC10's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for QC10?
Key metric: As QC10 is an unprofitable bank we use its Price-To-Book Ratio for relative valuation analysis.
The above table shows the Price to Book ratio for QC10. This is calculated by dividing QC10's market cap by their current
book value.
What is QC10's PB Ratio?
PB Ratio
0.5x
Book
US$8.07b
Market Cap
US$4.43b
QC10 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Book vs Industry: QC10 is good value based on its Price-To-Book Ratio (0.6x) compared to the European Banks industry average (0.8x).
Price to Book Ratio vs Fair Ratio
What is QC10's PB Ratio
compared to its
Fair PB Ratio?
This is the expected PB Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
QC10 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio
0.5x
Fair PB Ratio
n/a
Price-To-Book vs Fair Ratio: Insufficient data to calculate QC10's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst QC10 forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
€9.20
€11.15
+21.2%
7.0%
€12.89
€9.67
n/a
14
Oct ’25
€10.00
€10.97
+9.7%
8.7%
€12.57
€9.43
n/a
14
Sep ’25
n/a
€10.57
0%
9.1%
€12.55
€8.97
n/a
14
Aug ’25
n/a
€11.28
0%
15.3%
€16.58
€9.21
n/a
14
Jul ’25
€9.00
€13.27
+47.5%
55.6%
€39.12
€9.78
n/a
14
Jun ’25
€8.95
€13.51
+50.9%
52.2%
€38.60
€9.65
n/a
15
May ’25
€7.42
€13.85
+86.6%
50.3%
€39.28
€9.82
n/a
16
Apr ’25
€9.12
€14.08
+54.4%
47.0%
€38.75
€8.30
n/a
17
Mar ’25
€9.98
€18.28
+83.3%
36.6%
€38.76
€9.69
n/a
17
Feb ’25
€16.35
€26.18
+60.1%
25.8%
€41.40
€16.56
n/a
16
Jan ’25
€28.35
€34.25
+20.8%
15.2%
€43.89
€21.95
n/a
17
Dec ’24
€25.74
€35.41
+37.6%
14.0%
€44.13
€22.06
n/a
17
Nov ’24
€26.76
€37.06
+38.5%
10.3%
€45.36
€31.18
€9.20
17
Oct ’24
€31.92
€41.98
+31.5%
10.0%
€48.24
€34.05
€10.00
17
Sep ’24
€33.90
€42.07
+24.1%
8.3%
€46.61
€32.90
n/a
16
Aug ’24
€37.68
€41.74
+10.8%
7.9%
€46.44
€32.78
n/a
16
Jul ’24
€30.66
€33.60
+9.6%
8.4%
€38.64
€27.60
€9.00
16
Jun ’24
€28.98
€32.79
+13.1%
7.4%
€35.92
€27.63
€8.95
17
May ’24
€26.91
€31.35
+16.5%
10.4%
€35.39
€24.50
€7.42
17
Apr ’24
€24.42
€30.21
+23.7%
9.4%
€35.95
€22.13
€9.12
16
Mar ’24
€24.86
€29.92
+20.4%
8.3%
€33.56
€26.56
€9.98
15
Feb ’24
€27.27
€29.06
+6.6%
9.3%
€32.77
€24.58
€16.35
14
Jan ’24
€24.12
€28.63
+18.7%
11.0%
€35.32
€24.02
€28.35
15
Dec ’23
€26.58
€31.31
+17.8%
14.6%
€41.90
€25.44
€25.74
13
Nov ’23
€28.09
€31.89
+13.5%
14.5%
€42.15
€25.59
€26.76
11
Analyst Forecast: Target price is less than 20% higher than the current share price.